Experimental lung drug to be tested on UK coronavirus patients
by Julia Kollewe from on (#50X8A)
Biotech firm Synairgen will trial SNG001 inhaler on 100 people in race to find cure
The UK biotech firm Synairgen is to trial its experimental lung drug in Covid-19 patients, joining the global race to find a treatment for coronavirus.
The company received the green light from UK regulators to conduct a trial of its lead drug SNG001 at NHS trusts across the country.
Continue reading...